๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Synthesis and characterization of the potent cannabinoid agonist [naphthyl-3H] WIN 55212-2 at high specific activity

โœ Scribed by Richard J. Seguin; Crist N. Filer


Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
79 KB
Volume
46
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

[Naphthylโ€^3^H] WIN 55212โ€2 was prepared at high specific activity by the catalytic tritiation of dibromo precursor 3. Product 4 was characterized by chromatography as well as tritium NMR and proven to be a useful radioligand. Copyright ยฉ 2002 John Wiley & Sons, Ltd.


๐Ÿ“œ SIMILAR VOLUMES


Synthesis and characterization of [vinyl
โœ David G. Ahern; Richard J. Seguin; Crist N. Filer ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 80 KB

## Abstract [Vinylideneโ€^3^H] (โˆ’)โ€ฮฑโ€Kainic acid was prepared by means of a Wittig reaction with a protected ketone precursor and has proved useful as a tool to study neuroexcitatory amino acid receptors. Copyright ยฉ 2002 John Wiley & Sons, Ltd.

An expedient synthesis of high specific
โœ Neile A. Grayson; Brian R. de Costa; Joannes T. M. Linders; Kenner C. Rice ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 319 KB ๐Ÿ‘ 1 views

## Abstract [^18^F]4โ€Fluoroโ€1โ€[1โ€(2โ€thienyl)cyclohexyl)]piperidine is a ligand potentially useful for positron emission tomography of the PCP/NMDA receptor complex in the mammalian brain. The tritiumโ€labelled title compound was synthesized in 5 steps starting with cyclohexanone. Catalytic tritiolys

The synthesis of three isotopomers of 2-
โœ Fengjiun Kuo; Dean K. Clodfelter; Nagy A. Farid; William J. Wheeler; Lennon H. M ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 184 KB

## Abstract Although fenofibrate (**1a**) is commercially available and clinically effective in lowering serum triglycerides, its activity and subโ€type selectivity at the PPARฮฑ receptors are only moderate; therefore, there exists a need for more potent and subโ€type selective PPARฮฑ agonists. To that